| Previous Close | 50.80 |
| Open | 50.98 |
| Bid | 50.11 x 400 |
| Ask | 52.00 x 100 |
| Day's Range | 50.62 - 51.00 |
| 52 Week Range | 37.38 - 51.13 |
| Volume | 5,692,833 |
| Avg. Volume | 6,392,669 |
| Market Cap | 88.2B |
| Beta | 1.54 |
| PE Ratio (TTM) | 52.89 |
| EPS (TTM) | 0.96 |
| Earnings Date | Oct 17, 2017 - Oct 23, 2017 |
| Dividend & Yield | 1.06 (2.08%) |
| Ex-Dividend Date | 2017-07-12 |
| 1y Target Est | 55.06 |
- Market Realist•4 hours ago
What Were Abbott’s Key Growth Drivers for 2Q17?
Abbott completed the acquisition of St. Jude Medical in January 2017. It contributed significantly to its 2Q17 sales.
- Market Realist•5 hours ago
Abbott Laboratories’ 2Q17 Results: Which Segment Fared Best?
In 2Q17, Abbott Laboratories' (ABT) Medical Devices segment reported a strong performance once again, registering a YoY sales growth of 89.2%.
- Market Realist•7 hours ago
Strong 2Q17 Results Trigger Rise in Abbott Stock
On July 20, 2017, Abbott Laboratories (ABT) released its 2Q17 earnings. That day, ABT stock rose more than 4.0% from its closing price of $49.40 on July 19, 2017.
